Skip to main content
LLY
NYSE Life Sciences

Lilly secures gene-editing tech license for kidney disease drugs in deal worth up to $1.9B

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1,066
Mkt Cap
$1.002T
52W Low
$623.78
52W High
$1,149.1
52W Position info
71% above low
Off High info
7.2% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LLY sits 71% above its 52-week low of $623.78.

Summary

Eli Lilly secured a licensing deal with Ascidian Therapeutics for their RNA exon-editing technology, targeting rare inherited kidney diseases. The agreement is valued at up to $1.9 billion, including an undisclosed upfront payment and future milestones. This move aligns with Lilly's ongoing strategy to expand its genetic medicine pipeline, adding a novel gene-editing approach without permanent DNA alteration. Ascidian will lead early research, with Lilly handling later development and commercialization.

At the time of this announcement, LLY was trading at $1,066.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1T. The 52-week trading range was $623.78 to $1,149.10. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 18, 2026, 3:04 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,381.18
Real-time Price: $1,355.82 info
Change: -$25.36 (-2%) info
Market Cap: $1.271T info
LLY
Nov 17, 2026, 11:18 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,416.23
Real-time Price: $1,355.82 info
Change: -$60.40 (-4%) info
Market Cap: $1.271T info
LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,355.82 info
Change: -$99.54 (-7%) info
Market Cap: $1.271T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,355.82 info
Change: -$96.88 (-7%) info
Market Cap: $1.271T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,355.82 info
Change: -$92.03 (-6%) info
Market Cap: $1.271T info